These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12053420)

  • 1. Challenges, choices, and Canada.
    Sanders JM
    Int J Technol Assess Health Care; 2002; 18(2):199-202. PubMed ID: 12053420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Canadian Coordinating Office for Health Technology Assessment.
    Battista RN; Feeny DH; Hodge MJ
    Int J Technol Assess Health Care; 1995; 11(1):102-16. PubMed ID: 7706007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health technology assessment in the United States. Past, present, and future.
    Eisenberg JM; Zarin D
    Int J Technol Assess Health Care; 2002; 18(2):192-8. PubMed ID: 12053419
    [No Abstract]   [Full Text] [Related]  

  • 4. Building Synergy between Regulatory and HTA Agencies beyond Processes and Procedures-Can We Effectively Align the Evidentiary Requirements? A Survey of Stakeholder Perceptions.
    Wang T; McAuslane N; Liberti L; Leufkens H; Hövels A
    Value Health; 2018 Jun; 21(6):707-714. PubMed ID: 29909876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health Technology Assessment (HTA) Case Studies: Factors Influencing Divergent HTA Reimbursement Recommendations in Australia, Canada, England, and Scotland.
    Allen N; Walker SR; Liberti L; Salek S
    Value Health; 2017 Mar; 20(3):320-328. PubMed ID: 28292476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health technology assessment, research, and implementation within a health region in Alberta, Canada.
    Lee RC; Marshall D; Waddell C; Hailey D; Juzwishin D
    Int J Technol Assess Health Care; 2003; 19(3):513-20. PubMed ID: 12962337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-ordinating health technology assessment in Canada: a European perspective.
    McDaid D
    Health Policy; 2003 Feb; 63(2):205-13. PubMed ID: 12543533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health technology assessment: decentralized and fragmented in the US compared to other countries.
    Perry S; Thamer M
    Health Policy; 1997 Jun; 40(3):177-98. PubMed ID: 10168751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges for the National Institute for Clinical Excellence.
    Maynard A; Bloor K; Freemantle N
    BMJ; 2004 Jul; 329(7459):227-9. PubMed ID: 15271837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A national policy for health care technology assessment.
    Perry S; Pillar B
    Med Care Rev; 1990; 47(4):401-17. PubMed ID: 10113012
    [No Abstract]   [Full Text] [Related]  

  • 11. Redefining health technology assessment in Canada: diversification of products and contextualization of findings.
    Lehoux P; Tailliez S; Denis JL; Hivon M
    Int J Technol Assess Health Care; 2004; 20(3):325-36. PubMed ID: 15446762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National Institute for Clinical Excellence and its value judgments.
    Rawlins MD; Culyer AJ
    BMJ; 2004 Jul; 329(7459):224-7. PubMed ID: 15271836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AHSCs: an indispensable partner for governments.
    Shugart I
    Healthc Pap; 2002; 2(3):80-4; discussion 111-4. PubMed ID: 12811134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Devolving healthcare delivery to regional health authorities: is health technology assessment prepared to follow?
    Gibis BR; Juzwishin D
    Healthc Manage Forum; 2003; 16(1):24-31. PubMed ID: 12908163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report from the Hungarian Coordinating Office for Health Technology Assessment (HCOHTA). Establishment of a national health technology assessment research unit.
    Int J Technol Assess Health Care; 1995; 11(1):122-4. PubMed ID: 7706010
    [No Abstract]   [Full Text] [Related]  

  • 16. Health technology assessment in Canada: diversity and evolution.
    Hailey DM
    Med J Aust; 2007 Sep; 187(5):286-8. PubMed ID: 17767434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "It all depends": conceptualizing public involvement in the context of health technology assessment agencies.
    Gauvin FP; Abelson J; Giacomini M; Eyles J; Lavis JN
    Soc Sci Med; 2010 May; 70(10):1518-26. PubMed ID: 20207061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-informed evidence-making.
    Chalkidou K; Walley T; Culyer A; Littlejohns P; Hoy A
    J Health Serv Res Policy; 2008 Jul; 13(3):167-73. PubMed ID: 18573766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LOCAL HEALTH TECHNOLOGY ASSESSMENT IN CANADA: CURRENT STATE AND NEXT STEPS.
    Martin J; Polisena J; Dendukuri N; Rhainds M; Sampietro-Colom L
    Int J Technol Assess Health Care; 2016 Jan; 32(3):175-80. PubMed ID: 27491840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there an alternative to a National Health Board for Technology Assessment?
    Lerner JC
    Med Interface; 1994 Jun; 7(6):123-6, 132. PubMed ID: 10135316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.